1-7 of 7
Cheng Li, Ph.D.
Close
Sort by
Journal Articles

Genome-Wide Analysis of Microdeletions and Identification of NF1 Inactivation in Acute Myelogenous Leukemia.

Sami Malek, MD, Peter Ouillette, Yin Wang, Yan Liu, Whitney Wright, Diane Roulston, Amanda L Dressel, RN, BSN, Judith Karp, Paula Bockenstedt, MD, Ammar Al-Zoubi, MD, Moshe Talpaz, Lisa Kujawski, MD, Yang Liu, Kerby Shedden, Sajid Shakhan, Cheng Li, Ph.D, Harry Paul Erba, MD, PhD, Brian Parkin
Journal: Blood
Blood (2009) 114 (22): 165.
https://doi.org/10.1182/blood.V114.22.165.165
Published: 2009
Journal Articles

Evolution of Genomic Changes and Their Significance in Myeloma.

Masood A Shammas, PhD, Herve Loiseau, Cheng Li, Ph.D, Leutz Buon, Samir B Amin, MBBS, Parantu Shah, PhD, King Ben, MD, Mariateresa Fulciniti, yu-Tzu Thai, PhD, Paul Richardson, M.D., Ph.D., Stephane Minvielle, Ph.D, Kenneth C. Anderson, Nikhil C. Munshi
Journal: Blood
Blood (2009) 114 (22): 605.
https://doi.org/10.1182/blood.V114.22.605.605
Published: 2009
Journal Articles

Whole Genome Paired End Sequencing Identifies Genomic Evolution in Myeloma.

Nikhil C. Munshi, Herve Avet-Loiseau, MD, PhD, Phil Stephens, PhD, Masood A Shammas, PhD, Cheng Li, Ph.D, Leutz Buon, PhD, Samir B Amin, MBBS, Parantu Shah, PhD, Benjamin King, MD, Mariateresa Fulciniti, PhD, Jagannath Pal, MBBS, PhD, Yu-Tzu Tai, PhD, Paul Richardson, M.D., Ph.D., Stephane Minvielle, Ph.D, Peter Campbell, MD, Kenneth C. Anderson, MD, Andrew Futreal, PhD
Journal: Blood
Blood (2009) 114 (22): 2846.
https://doi.org/10.1182/blood.V114.22.2846.2846
Published: 2009
Journal Articles

High-Throughput Microrna Profiling in Patients with Waldenstrom’s Macroglobulinemia.

Sophia Adamia, Ph.D, Samir B Amin, MBBS, Cheng Li, Ph.D, Christopher J Patterson, Herve AvetLoiseau, MD, Stephane Minvielle, Ph.D, Philippe Moreau, MD, Kenneth C Anderson, MD, Nikhil C. Munshi, MD, Steven Treon, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 1704.
https://doi.org/10.1182/blood.V112.11.1704.1704
Published: 2008
Journal Articles

Microrna Expression Profile Identifies Distinct Clinically Relevant Sub-Groups in Multiple Myeloma: Novel Prognostic Markers and Potential Targets for Therapy

Sophia Adamia, Ph.D, Herve AvetLoiseau, MD, Samirkumar B Amin, MBBS, Yu-Tzu Tai, PhD, Steven P. Treon, MD, PhD, Philippe Moreau, MD, Stephane Minvielle, Ph.D, Cheng Li, Ph.D, Kenneth C Anderson, MD, Nikhil C. Munshi, MD
Journal: Blood
Blood (2008) 112 (11): 96.
https://doi.org/10.1182/blood.V112.11.96.96
Published: 2008
Journal Articles

Acquisition of New In Vivo Genomic Change over Time in Multiple Myeloma.

Yu-Tzu Tai, PhD, Leutz Buon, M.S., Benjamin King, B.S., Cheng Li Cheng Li, Ph.D., Peter Burger Peter Burger, B.S., Xian-Feng Li, M.S., Weihua Song, M.D., Robert Schlossman, M.D., Paul Richardson, M.D., Kenneth C. Anderson, M.D., Nikhil Munshi, M.D.
Journal: Blood
Blood (2007) 110 (11): 2481.
https://doi.org/10.1182/blood.V110.11.2481.2481
Published: 2007
Journal Articles

Genomic Evolution of Multiple Myeloma In Vivo over Time.

Yu-Tzu Tai, PhD, Benjamin King, B.S., Cheng Li, Ph.D., XianFeng Li, M.S., Peter Burger, B.S., Weihua Song, M.D., Masood Shammas, Ph.D., Robert Schlossman, M.D., Paul Richardson, M.D., Kenneth C. Anderson, M.D., Nikhil C. Munshi, M.D.
Journal: Blood
Blood (2006) 108 (11): 3400.
https://doi.org/10.1182/blood.V108.11.3400.3400
Published: 2006